Sevelamer Hydrochloride: Brands, Price & Uses in Bangladesh

Sevelamer Hydrochloride is a non-calcium, non-metal phosphate-binding agent primarily used in the management of hyperphosphatemia (elevated blood phosphorus) in patients with chronic kidney disease (CKD).

Established / FDA-approved use

• Control of serum phosphorus levels in adult patients with chronic kidney disease who are on dialysis (hemodialysis or peritoneal dialysis).

Guideline-supported / broader nephrology use

• Some patients with advanced CKD not yet on dialysis (CKD stage 4-5) are managed with Sevelamer Hydrochloride as part of an overall phosphorus-control strategy, guided by nephrology assessment and local guidelines, alongside dietary phosphate restriction.

Sevelamer Hydrochloride does not treat the underlying kidney disease itself; it is used as part of a broader chronic kidney disease/dialysis management plan that also requires regular monitoring of serum phosphorus and calcium by the treating nephrology team.

Adult dose (patients on dialysis)

The dose of Sevelamer Hydrochloride is individualized and titrated in increments (commonly by 400-800 mg per meal) at 2-week intervals or as directed by the treating physician, based on serial serum phosphorus measurements, aiming for a target phosphorus level.

Pediatric dose

Safety and efficacy of Sevelamer Hydrochloride have not been well established in pediatric patients; use in children should only occur under close nephrology supervision, if at all.

Renal/hepatic adjustment

Sevelamer Hydrochloride is not systemically absorbed, so no specific dose adjustment based on renal or hepatic function is established beyond the underlying indication itself (chronic kidney disease/dialysis).

Administration instructions

• Must be taken with meals (or immediately before/after meals) - it is not effective and should not be taken apart from food, since its phosphate-binding action depends on being present in the gut together with dietary phosphate.
• Tablets should be swallowed whole and not crushed, chewed, or broken.
• Do not stop or change the dose of Sevelamer Hydrochloride without consulting the treating physician, since serum phosphorus must be monitored regularly to guide dose changes.

The most common side effects of Sevelamer Hydrochloride involve the gastrointestinal system and can be significant, especially with higher pill burden:

• Nausea and vomiting
• Dyspepsia (indigestion)
• Diarrhea
• Constipation
• Abdominal pain/bloating

Rare but serious effects include bowel obstruction or impaction, particularly in patients with pre-existing gastrointestinal motility disorders, prior gastrointestinal surgery, or other gastrointestinal risk factors. Patients should seek prompt medical attention for severe abdominal pain, inability to pass stool, or persistent vomiting.